The new facility is based at the pharmaceutical company’s Havant site and has cost £26.3 million. This is a significant investment by Pfizer and is evidence to the UK’s strengths in life sciences and the pool of highly skilled pharmaceutical workers we have to offer. In fact, in 2009/2010, the UK alone attracted 173 life sciences investment projects, generating nearly 8,500 jobs.
Science Minister, David Willets stated, “Pfizer’s commitment to the UK is a big win for our life science and manufacturing base. I’m hugely encouraged that even in these tough economic times the world’s largest research-based biopharmaceutical company has chosen the UK to make this significant investment.
“The Government is determined to ensure that the UK has one of the leading business environments in the world for the life sciences and remains a global force in this field.”
Are you looking for a new role in the UK pharmaceutical industry? Click here to search our current pharmaceutical jobs online now.